Saudi Heart Association, AstraZeneca sign deal to boost cardiac care

RIYADH: The Saudi Heart Association has signed a memorandum of understanding with AstraZeneca to support cardiac research, train healthcare practitioners and improve care for hypertension patients, SPA reported on Friday.
The agreement comes as cardiovascular disease remains a major public health challenge in the Kingdom. Figures from the General Authority for Statistics show that 7.9 percent of people aged 15 and over had hypertension in 2024, while 1.5 percent had cardiovascular disease.
Cardiovascular diseases are disorders of the heart and blood vessels, including coronary heart disease and cerebrovascular disease, which affect the blood vessels supplying the heart and the brain, according to the World Health Organization.
Kutipan awal dari Arab News, ditulis oleh Ghadi Joudah. Hak cipta artikel milik penerbit.



